Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-12-16

FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PENTASA (mesalamine) to update the product labeling. The submission was filed by Takeda Pharmaceuticals America, Inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

SUPPL AP for PENTASA (MESALAMINE)